ClinicalTrials.Veeva

Menu
N

New York Medical College | Boston Children's Hospital - Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dociparstat
Cytarabine
Azacitidine
Sapacitabine
FT-2102
CMTX-101

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

CMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of...

Enrolling
Persistent Infection
Cystic Fibrosis
Drug: Placebo
Drug: CMTX-101

A phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, phage kinetics, and efficacy of inhaled AP-PA02 a...

Enrolling
Lung Infection
Non-cystic Fibrosis Bronchiectasis
Other: Placebo
Biological: AP-PA02

Trial sponsors

A
Chimerix logo
C
C
Forma Therapeutics logo
Johns Hopkins University logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems